University spinout Complement Therapeutics secures €72 million to tackle diseases including leading cause of blindness

Press/Media: Other

Description

https://www.manchester.ac.uk/discover/news/university-spinout-complement-therapeutics-secures-72-million-to-tackle-diseases-including-leading-cause-of-blindness/

Period20 Apr 2023

Media contributions

1

Media contributions

  • TitleUniversity spinout Complement Therapeutics secures €72 million to tackle diseases including leading cause of blindness
    Country/TerritoryUnited Kingdom
    Date20/04/23
    PersonsRichard Unwin
View all 1
View less

Related content